The essential role of recombinant phage display antibody libraries
Drug Target Review
OCTOBER 3, 2024
Overcoming traditional antibody generation limitations with recombinant technologies Antibodies remain essential tools in this ever-changing field for preclinical bioanalysis and drug monitoring through ligand-binding assays (LBAs). FDA no longer needs to require animal tests before human drug trials [Internet].
52 
Let's personalize your content